Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer

Journal of Nuclear Medicine

Volumn 54, Issue 11, 2013, Pages 1883-1889

  Scalici, Jennifer M ^a   Thomas, Stephanie ^b   Harrer, Christine ^a   Raines, Timothy A ^a   Curran, Joanna ^a   Atkins, Kristen A ^a,c   Conaway, Mark R ^c,d   Duska, Linda ^a,c   Kelly, Kimberly A ^b,c   Slack Davis, Jill K ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b University of Virginia   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Metastasis; Ovarian cancer; SPECT CT Imaging; VCAM 1

Indexed keywords

CARBOPLATIN; CONTRAST MEDIUM; INDIUM 111; INDIUM TETRAMERIC VCAM 1 PEPTIDE IN 111; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; TUMOR MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING PROBE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MESOTHELIUM CELL; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT MONITORING; PERITONEAL BIOPSY; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; SCINTISCANNING; TREATMENT OUTCOME; TUMOR CELL LINE; OVARY TUMOR; SPECT/CT IMAGING; VCAM-1;

ANIMALS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1;

METASTASIS; OVARIAN CANCER; SPECT/CT IMAGING; VCAM-1;

EID: 84891712377     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.117796     Document Type: Article

References (16)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer. 2005;15(suppl 1):3-11.
3. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol. 2008;108:276-281.
4. Hou JY, Kelly MG, Yu H, et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol. 2007;105: 211-217.
5. Rustin GJ, van der Burg ME, Griffin CL, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial. Lancet. 2010;376:1155-1163.
6. Rustin GJ. Use of CA-125 to assess response to new agents in ovarian cancer trials. J Clin Oncol. 2003;21:187s-193s.
7. Eisenhauer EA. Optimal assessment of response in ovarian cancer. Ann Oncol. 2011;22(suppl 8):viii49-viii51.
8. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res. 2009;69:1469-1476.
9. Kelly KA, Nahrendorf M, Yu AM, Reynolds F, Weissleder R. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol. 2006;8:201-207.
10. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504-1511.
11. Nahrendorf M, Keliher E, Panizzi P, et al. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging. 2009;2: 1213-1222.
12. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res. 2005;96:327-336.
13. Kelly KA, Waterman P, Weissleder R. In vivo imaging of molecularly targeted phage. Neoplasia. 2006;8:1011-1018.
14. Cannistra SA, Ottensmeier C, Tidy J, DeFranzo B. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol. 1994;22:996-1002.
15. van der Vijgh WJ. Clinical pharmacokinetics of carboplatin. Clin Pharmacokinet. 1991;21:242-261.
16. Markman M, Rothman R, Hakes T, et al. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol. 1991;9:389-393.